Oxford Society
of Ageing and Longevity
We are a student-led organisation with the goal of accelerating the process of bringing ageing under medical control by galvanizing widespread support for the up-and-coming field of rejuvenation biotechnology.
A Cure for Ageing?
We treat cancer, visual impairment, heart disease and other ailments individually. The list is vast and extensive. But what if we could treat the root cause of nearly all disease? What if we could cure aging itself?
Controlling Ageing is within our reach.
Why is ageing a problem
Ageing is the biggest killer worldwide, and also the largest source of morbidity.
A world without ageing
Imagine a world in which everyone’s biological age is halted at 20-30 years.
What is ageing
Damage that accumulates over time, which exponentially increases the risk of the diseases.
Slowing the clock
In the lab, various anti-ageing approaches can extend healthy lifespan
Looking for more videos? Visit our past events page.
Seem far fetched?
We know, we know… But it’s a lot more plausible than it sounds. For the first time in human history we’re at a convergent point of CRISPR, Epigenetics, Genome-Wide Association Studies, Artificial Intelligence, Gene Therapy, and a whole slew of other new areas of growth in the coming decade.
Research Highlights
Cellular Senescence and Aging: Can We Turn Back the Clock?
Contributed by: Annabelle Hutchinson Cellular Senescence and Aging: Can We Turn Back the Clock? Cellular senescence is a biological process in which cells lose their ability to divide and function correctly. It's an intrinsic component of aging and has been associated...
Optimal Protein Consumption for Longevity
Contributed by: Annabelle Hutchinson When it comes to longevity, one of the first questions people ask is what they should eat. Unfortunately, nutritional epidemiology is plagued by faulty methods of measurement and analysis that lead to biased results, low internal...
EQT Life Sciences Announces €260mm Dementia Fund
Global investment firm EQT Life Sciences announced the close of its €260 million LSP Dementia Fund, outstripping its target fund size of €100 million. EQT is Europe’s largest healthcare buyout firm, with approximately €113.0 billion in assets under management....
Let’s Get Started
Sign up to receive regular newsletter updates!
Sponsored By
